FDA Panel Rejects Pravastatin/Aspirin Combo. Bristol-Myers-Squibb made a play for this comibation to maintain a market share for pravachol ... which will go generic soon. Nice try.
« Docnotesis my old weblog. Haven't | Main | Postgraduate Medicine: Patient Notesare another »
January 21, 2002
Search
Recent Posts
- It's not about the technology
- Seven e-mail patterns for more efficient work
- 12 years of blogging .. about medicine, technology and their intersection ...
- On Platforms ..
- PREVENT SPAM! - Marathon Fundraising
- Oesh Running Shoe Review
- Google+
- Health IT Workforce Curriculum - initial impression
- "compliance"
- Google Health Was a Dumb Idea Anyway ...
My Other Accounts
Recent Comments